How did you decide to participate in the Biomapas Academy?
When I used to walk past a pharmacy every day, I could never stop dreaming about being able to help people and develop innovative pharmaceuticals. So while studying biomedical sciences, I became interested in the drug development paths, which led me to medicinal chemistry. And one day at the university, I saw a poster about the Biomapas Academy, which could help me understand what, how, where, and when happens to pharmaceutical products during the whole journey to reach us, so I signed up for it without hesitation. Even though I am usually not a lucky person, I was selected to be one of the participants, which surprised me!
How was your experience regarding the Academy?
During the few months, I deepened my existing knowledge of drug development stages and expanded it to learn more about drug regulation and pharmacovigilance. After graduating from the Academy, I got the opportunity to try out regulatory affairs as part of Biomapas – I completed a summer internship in the Regulatory Affairs department.
How do you feel after graduating from the Academy?
I will never forget this practice in my life, not only because it fulfilled what I was looking for, but it let me realize that I want to return to this company after my graduation and put my accumulated knowledge to use. Thanks again to all Biomapas staff for their insights and advice, and I hope to see you soon.
Biomapas Academy
What is Clinical Research? Regulatory Affairs? Pharmacovigilance?
Case Study: Specialised Rescue Studies in Georgia
Discover how we successfully supported late‑phase clinical trials in Georgia by overcoming operational constraints, accelerating study start‑up, and restoring delivery confidence in complex research environments. This case study highlights three real‑world success...
Comprehensive Guide to Medical Information and Pharmacovigilance Integration
Discover how integrated Medical Information and Pharmacovigilance workflows enhance compliance, improve safety, and streamline regulatory processes.
Biomapas Insights: From Hope to Global Impact – How Elpida Accelerated Gene Therapy for Rare Diseases
In this Biomapas Insights episode, Martijn van de Leur, Chief Commercial Officer, speaks with Terry Pirovolakis, CEO of Elpida Therapeutics, the organisation that grew out of the CureSPG50 advocacy movement. Together, they explore how a parent-led mission to help...
Biomapas Insights: Selecting the Right CRO at the right time – What Biotechs Need to Know
Expert insights on timing, selection criteria, and early-phase clinical trial strategy for choosing the right CRO in biotech development.
Running Pan‑European Multi‑Regional Trials with Flexible FSP Models
Discover how flexible FSP models help sponsors run multi-country clinical trials across Europe with greater control, speed, and regional alignment.
Choosing the Right QPPV Partner for EU and Global Compliance
Explore the essential functions of a QPPV and discover how to choose the right partner for pharmacovigilance.
How to achieve Multi-Region Pharmacovigilance Compliance: Critical Lessons from CIS and MENA
Explore the challenges of multi-region pharmacovigilance and learn strategies for compliance in CIS and MENA markets.
Enhancing Patient Recruitment in Niche Markets Through Clinical Trial Outsourcing
Explore clinical trial outsourcing and its role in overcoming recruitment challenges in clinical research for small biotech companies.
The use of AI/Automation in Pharmacovigilance: Ensuring Safety through Robust Processes
Discover how AI and automation are transforming pharmacovigilance, including Veeva’s signal management solutions, the role of NLP and machine learning in safety workflows, and future trends in AI.
Signal Detection: An Integrated Approach to Pharmacovigilance & Regulatory Compliance
Discover how efficient signal detection manages safety risks, ensuring compliance with global regulations.
